Alignment Healthcare (ALHC) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Alignment Healthcare

NasdaqGS•Healthcare•Healthcare Plans

$8.35-0.35(-0.04%)After hours

Market Cap

$1.73B

P/E

42.6x

P/S

0.4x

P/B

6.5x

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.

How this company scores

GoodMetricSide Score: 79/100

Strongest: Growth (22/25); weakest: Profitability (16/25).

Profitability16/25

Growth22/25

Balance Sheet & Red Flags21/25

Cash & Earnings Quality20/25

Strengths

Growing revenueRising free cash flowHigh ROERising earnings

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 42.6x5y range 42.6x – 174.7x

P/S · 0.4x5y range 0.4x – 1.8x

Currently below its 19-quarter median.

P/B · 6.5x5y range 6.5x – 33.3x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 4 quarters — monitor for earnings quality deterioration.

Price & Volume

Market Cap $1.73B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $4.58B
Q. Revenue: $1.34B
TTM EBITDA: $86.50M
TTM Op. Income: $55.00M
Q. Op. Income: $42.10M
TTM Net Income: $40.70M
Q. Net Income: $36.56M
EPS: $0.18
Shares Out.: $207.45M

$4.58B in TTM revenue grew 37.2% YoY, reaching $1.34B last quarter. TTM EBITDA of $86.50M and TTM operating income of $55.00M show growth is flowing through to the bottom line. TTM net income of $40.70M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin: 3.7%
Op. Margin: 3.2%
Net Margin: 2.7%

Op. margin of 3.2% is up 0.9% YoY — cost efficiency is improving. Net margin at 2.7% Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 42.6x
P/S Ratio: 0.4x
P/B Ratio: 6.5x

At 42.6x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 0.4x and P/B of 6.5x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is up 0% — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $1.28B
Cash: $693.45M
Long-Term Debt: $324.06M
Book Value: $265.13M
D/E Ratio: 1.2
Debt/EBITDA: 6.5

With $1.28B in assets and $324.06M in long-term debt, D/E is 1.2and book value is $265.13M — moderate leverage. Across the last 8 quarters, debt/equity has fallen for 6 consecutive quarters — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $-17.31M
TTM Free Cash Flow: $177.51M
FCF Margin: 3.9%
FCF / Net Income: 4.4

TTM FCF of $177.51M on $-17.31M in operating cash flow. The FCF / Net Income ratio of 4.4x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is up 525% — a weakening trend.